KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Other Accumulated Expenses: 2010-2024

Historic Other Accumulated Expenses for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $88,000.

  • TherapeuticsMD's Other Accumulated Expenses was N/A to $301,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $301,000, marking a year-over-year change of. This contributed to the annual value of $88,000 for FY2024, which is 78.48% down from last year.
  • Latest data reveals that TherapeuticsMD reported Other Accumulated Expenses of $88,000 as of FY2024, which was down 78.48% from $409,000 recorded in FY2023.
  • TherapeuticsMD's 5-year Other Accumulated Expenses high stood at $18.8 million for FY2022, and its period low was $88,000 during FY2024.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $409,000 (2023), whereas its average is $6.4 million.
  • Per our database at Business Quant, TherapeuticsMD's Other Accumulated Expenses surged by 580.86% in 2021 and then slumped by 97.83% in 2023.
  • Over the past 5 years, TherapeuticsMD's Other Accumulated Expenses (Yearly) stood at $2.0 million in 2020, then surged by 580.86% to $13.3 million in 2021, then skyrocketed by 41.30% to $18.8 million in 2022, then plummeted by 97.83% to $409,000 in 2023, then plummeted by 78.48% to $88,000 in 2024.